ArticleAnti-cancer drugs2013

Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer.

Jingquan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.